Recent efforts to legalize marijuana in New York and New Jersey have been stalled \u2014 but not killed \u2014 by disputes over how exactly to divvy up the revenues from marijuana sales and by worries about drugged driving. Those are both important issues. But another concern should be at the center of this debate: the medical implications of legalizing marijuana, particularly for young people.<\/p>\n
It\u2019s tempting to think marijuana is a harmless substance that poses no threat to teens and young adults. The medical facts, however, reveal a different reality.<\/p>\n
Numerous studies show that marijuana can have a deleterious impact<\/a> on cognitive development in adolescents, impairing executive function<\/a>, processing speed<\/a>, memory<\/a>, attention span and concentration<\/a>. The damage is measurable with an I.Q. test. Researchers who tracked subjects from childhood through age 38found a consequential I.Q. decline<\/a> over the 25-year period among adolescents who consistently used marijuana every week. In addition, studies have shown that substantial adolescent exposure to marijuana may be a predictor of opioid use disorders<\/a>.<\/p>\n The reason the adolescent brain is so vulnerable to the effect of drugs is that the brain \u2014 especially the prefrontal cortex, which controls decision making, judgment and impulsivity \u2014 is still developing in adolescents and young adults until age 25.<\/p>\n Read it all<\/a>.<\/p>\n It\u2019s tempting to think marijuana is a harmless substance that poses no threat to teens and young adults. The medical facts, however, reveal a different reality, write two physicians. https:\/\/t.co\/LOBE3uIh4Y<\/a><\/p>\n \u2014 New York Times Opinion (@nytopinion) June 16, 2019<\/a><\/p><\/blockquote>\n\n